Partners
The IRC gratefully acknowledges the support of the following lead institutions and public and private sector partners, past and present:
Lead Institutions
- The Ottawa Hospital Research Institute (Canada)
- The University of Ottawa (Canada)
- The University of Toronto (Canada)
- The Hospital for Sick Children (Toronto)
- Mount Sinai Hospital (New York)
- IGBMC (Institute of Genetics and Molecular and Cellular Biology) (France)
- Technische Universitat Dresden (Germany)
- Wellcome Trust, Sanger Institute (UK)
- Erasmus University (Netherlands)
- Genome Institute of Singapore
- The University of Queensland (Australia)
- Invitrogen Corporation (USA) now Life Technologies
Public and Private Sector Partners
- Ontario Ministry of Research and Innovation (Canada)
- AFM (France)
- Agency for Science, Technology and Research (Singapore)
- ANR (France)
- National Health and Medical Research Council (Australia)
- BMBF (Germany)
- Canadian Institutes of Health Research (Canada)
- CIHR Institute of Genetics (Canada)
- Canada Foundation For Innovation
- Genome Canada
- Genopole (France)
- NGFN (Germany)
- National Institutes of Health (USA)
- Ontario Genomics Institute (Canada)
- The Stem Cell Network (Canada)
- European Commission
- Wellcome Trust
